Skip to main content

Together we are beating cancer

Donate now
  • For Researchers

Latest winner in our Research is Beautiful campaign

by Phil Prime | In depth

3 July 2024

0 comments 0 comments

3D-bioprinted Tumour

After some very strong entries to our Research is Beautiful campaign – we have our June winner!

Our Research is beautiful image campaign highlights images that showcase your research – from your science, to the people in your lab and everything that surrounds it.

Congratulations to Michaela Macdonald from Carcinotech Ltd for the winning image of the past month. Her picture captures a 3D-bioprinted living tumour, derived from donor glioblastoma tissue. Blue hues highlight cell nuclei, while pink and turquoise reveal cancer-associated fibroblasts.

Carcinotech 3D-bioprinted Tumour
3D-bioprinted living tumour, derived from donor glioblastoma tissue. Captured under a Leica DMi8 microscope, blue hues highlight cell nuclei, while pink and turquoise reveal cancer-associated fibroblasts.
Michaela Macdonald
Michaela Macdonald is an imaging scientist at Carcinotech

Carcinotech specialises in crafting these bioengineered tumours from patient biopsies, offering researchers and drug developers an alternative to animal models for screening and testing cancer therapies.

Send your images

To enter, e-mail your photos to [email protected] with a short caption and your contact details. Images should be sent as JPEG files and, ideally, be at least 2000px. Feel free to email this address if you have any questions.

Each month, a panel of CRUK staff will review the submissions and choose the best image(s) that month. Successful entrants will be notified directly and the image(s) will be showcased on Cancer News for Researchers and our social-media platforms X and LinkedIn.

The campaign is open to UK residents aged 18 or over. Please ensure before submitting an entry that you have read the campaign terms and conditions.

T&Cs here

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.